Patents Assigned to Australian Nuclear Science and Technology Organisation
  • Publication number: 20120311933
    Abstract: Described herein is a method for determining the presence or absence of anomalous radioactive materials in a target in a detection zone. In the method, a target gamma ray spectrum is obtained from the target and a target data set is prepared from the target gamma ray spectrum. This data set comprise a plurality of intensity values, each intensity value being associated with an energy bin representing a gamma ray energy or range of gamma ray energies in the target gamma ray spectrum. The target data set is then pre-processed and projected into a principal component space which contains a pre-processed data library projected into the principal component space. A distance is then determined between the projected pre-processed target data set and one or more clusters of the projected pre-processed data library in the principal component space and this distance is compared with a predetermined threshold distance so as to determine if an anomalous radioactive material is present in the target.
    Type: Application
    Filed: November 11, 2010
    Publication date: December 13, 2012
    Applicant: Australian Nuclear Science and Technology Organisation
    Inventors: Mark Reinhard, David Boardman
  • Publication number: 20110266427
    Abstract: The invention provides a test device for assessing the detection capability of an X-ray system with a medium and/or large tunnel size. The device comprises a support and at least one test module mounted on the support. The device may optionally also comprise a stand which holds the support at a predetermined angle to the horizontal. The test module, or at least one of the test modules, is capable of being used in a test for an aspect of the detection capability.
    Type: Application
    Filed: June 25, 2009
    Publication date: November 3, 2011
    Applicant: AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION
    Inventors: Ned Blagojevic, Dudley Creagh
  • Patent number: 7951555
    Abstract: The invention provides a membrane comprising a gel reinforced by a support. The membrane has opposing surfaces and a thickness between said surfaces. The gel communicates between the opposing surfaces and allows diffusion of a nutrient solution through the membrane. A bioreactor is also provided, comprising a membrane-supporting structure, and a membrane according to the invention supported on the membrane-supporting structure.
    Type: Grant
    Filed: May 18, 2005
    Date of Patent: May 31, 2011
    Assignee: Australian Nuclear Science and Technology Organisation
    Inventors: Anthony Patrick Andrew Taylor, Kim Suzanne Finnie, John Bartlett, Peter James Holden
  • Publication number: 20110083531
    Abstract: The invention relates to a method for recovering gold from an acid digest of a gold-containing copper anode slime. The acid digest is selectively extracted with an alcohol having low miscibility with water. Gold is then recovered from the resulting alcoholic extract.
    Type: Application
    Filed: February 27, 2009
    Publication date: April 14, 2011
    Applicant: AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION
    Inventor: Karin Soldenhoff
  • Patent number: 7897048
    Abstract: The present invention discloses a membrane, optionally for use in sewage treatment. The membrane comprises a support membrane having a gas face biolayer on a gas face of the membrane and/or in the support membrane near the gas face, and a liquid face biolayer on a liquid face of the membrane and/or in the support membrane near the liquid face.
    Type: Grant
    Filed: November 17, 2006
    Date of Patent: March 1, 2011
    Assignee: Australian Nuclear Science and Technology Organisation
    Inventor: Anthony Patrick Andrew Taylor
  • Publication number: 20090252808
    Abstract: A process is provided for releasably encapsulating a biological entity. The process comprise combining a solution of a surfactant in a non-polar solvent with a precursor material and the biological entity to form an emulsion. The emulsion comprises a polar phase dispersed in a non-polar phase, wherein the polar phase comprises the biological entity. The particles comprising the biological entity are then formed from the polar phase.
    Type: Application
    Filed: December 20, 2005
    Publication date: October 8, 2009
    Applicant: AUSTRALIAN NUCLEAR SCIENCE & TECHNOLOGY ORGANISATION
    Inventors: Kim Suzanne Finnie, David Jacques, Christophe Jean Alexandre Barbe, Linggen Kong
  • Publication number: 20090230295
    Abstract: A method of determining the distance, from a reference point, of a tracer emitting radiation comprising a first component emitted at a first known energy level and a second component emitted at a second known energy level, the intensity of a penetrating portion of the first component that penetrates a substance between the tracer and the reference point and the intensity of a penetrating portion of the second component of the radiation that penetrates the substance being a function of the rate of gamma radiation emission of the tracer as well as of the distance of the tracer from the reference point, the method comprising: a) measuring the intensity of the first penetrating portion and the intensity of the second penetrating portion; b) determining the ratio of the intensity of the first penetrating portion to the intensity of the second penetrating portion; and c) determining the distance of the tracer from the reference point.
    Type: Application
    Filed: March 29, 2007
    Publication date: September 17, 2009
    Applicant: Australian Nuclear Science & Technology Organisation
    Inventors: Christopher Leslie Waring, Peter Lewis Airey, Yury A. Stepanyants
  • Patent number: 7585521
    Abstract: Controlled release ceramic particles, processes for their preparation, controlled release ceramic particles prepared by such processes, compositions comprising such controlled release ceramic particles and methods of using controlled release ceramic particles are described. In one form each of the controlled release ceramic particles has an active material(s) substantially homogeneously dispersed throughout the particles, wherein the active material(s) is capable of being released from said particles, and the active material(s) in said particles is substantially protected from degradation until release of the active material(s) from the particles.
    Type: Grant
    Filed: July 11, 2008
    Date of Patent: September 8, 2009
    Assignee: Australian Nuclear Science & Technology Organisation
    Inventors: Christophe Jean Alexandre Barbé, John Bartlett
  • Publication number: 20090114809
    Abstract: The present invention relates to a method for determining at least one ratio of different isotopes of at least one element in a sample. The method comprises ionizing the sample to produce ions of the different isotopes of the at least one element, the ions being selected from the group consisting of: multiply charged atomic positive ions, single charged positive ions for hydrogen and single charged positive ions for deuterium, separating the charged positive ions of the different isotopes of the at least one element according to their mass-to-charge ratios, and determining at least one ratio of the different isotopes of said at least one element separated in the previous step. The invention also relates to an apparatus for performing the above method.
    Type: Application
    Filed: September 1, 2006
    Publication date: May 7, 2009
    Applicant: Australian Nuclear Science & Technology Organisation
    Inventors: Michael Hotchkis, Christopher Leslie Waring
  • Patent number: 7357948
    Abstract: Controlled release ceramic particles, processes for their preparation, controlled release ceramic particles prepared by such processes, compositions comprising such controlled release ceramic particles and methods of using controlled release ceramic particles are described. In one form each of the controlled release ceramic particles has an active material(s) substantially homogeneously dispersed throughout the particles, wherein the active material(s) is capable of being released from said particles, and the active material(s) in said particles is substantially protected from degradation until release of the active material(s) from the particles.
    Type: Grant
    Filed: August 20, 2007
    Date of Patent: April 15, 2008
    Assignee: Australian Nuclear Science & Technology Organisation
    Inventors: Christophe Jean Alexandre Barbé, John Bartlett
  • Patent number: 7354602
    Abstract: Controlled release ceramic particles, processes for their preparation, controlled release ceramic particles prepared by such processes, compositions comprising such controlled release ceramic particles and methods of using controlled release ceramic particles are described. In one form each of the controlled release ceramic particles has an active material(s) substantially homogeneously dispersed throughout the particles, wherein the active material(s) is capable of being released from said particles, and the active material(s) in said particles is substantially protected from degradation until release of the active material(s) from the particles.
    Type: Grant
    Filed: August 20, 2007
    Date of Patent: April 8, 2008
    Assignee: Australian Nuclear Science & Technology Organisation
    Inventors: Christophe Jean Alexandre Barbé, John Bartlett
  • Patent number: 7354603
    Abstract: Controlled release ceramic particles, processes for their preparation, controlled release ceramic particles prepared by such processes, compositions comprising such controlled release ceramic particles and methods of using controlled release ceramic particles are described. In one form each of the controlled release ceramic particles has an active material(s) substantially homogeneously dispersed throughout the particles, wherein the active material(s) is capable of being released from said particles, and the active material(s) in said particles is substantially protected from degradation until release of the active material(s) from the particles.
    Type: Grant
    Filed: August 20, 2007
    Date of Patent: April 8, 2008
    Assignee: Australian Nuclear Science & Technology Organisation
    Inventors: Christophe Jean Alexandre Barbé, John Bartlett
  • Patent number: 7311840
    Abstract: The invention relates to processes and compositions for at least partially removing cations of one or more metals selected from the group consisting of caesium, strontium, lead, silver, transition metals, lanthanides and actinides from a liquid containing the cations. The process comprises contacting the liquid with a sorbent material in an amount and for a time sufficient to at least reduce the concentration of the cations, wherein the sorbent material is a metal oxide composition having the empirical formula Ax/n[ByM1-yO3+?]x.
    Type: Grant
    Filed: May 31, 2001
    Date of Patent: December 25, 2007
    Assignee: Australian Nuclear Science and Technology Organisation
    Inventor: Vittorio Luca
  • Patent number: 7258874
    Abstract: Controlled release ceramic particles, processes for their preparation, controlled release ceramic particles prepared by such processes, compositions comprising such controlled release ceramic particles and methods of using controlled release ceramic particles are described. In one form each of the controlled release ceramic particles has an active material(s) substantially homogeneously dispersed throughout the particles, wherein the active material(s) is capable of being released from said particles, and the active material(s) in said particles is substantially protected from degradation until release of the active material(s) from the particles.
    Type: Grant
    Filed: February 21, 2001
    Date of Patent: August 21, 2007
    Assignee: Australian Nuclear Sciences & Technology Organisation
    Inventors: Christophe Jean Alexandre Barbe, John Bartlett
  • Publication number: 20060249461
    Abstract: The invention relates to processes and compositions for at least partially removing cations of one or more metals selected from the group consisting of caesium, strontium, lead, silver, transition metals, lanthanides and actinides from a liquid containing the cations. The process comprises contacting the liquid with a sorbent material in an amount and for a time sufficient to at least reduce the concentration of the cations, wherein the sorbent material is a metal oxide composition having the empirical formula Ax/n[ByM1-yO3+?]x.
    Type: Application
    Filed: May 31, 2001
    Publication date: November 9, 2006
    Applicant: Australian Nuclear Science & Technology Organisation
    Inventor: Vittorio Luca
  • Patent number: 7108845
    Abstract: There is provided a method of synthesis of a radiolabelled platinum chemotherapeutic agent comprising the steps of: converting a metal halide to a radiolabelled platinum halide wherein the radiolabel is a radioisotope of Pt; and synthesizing the radiolabelled platinum chemotherapeutic agent from the radiolabelled platinum halide.
    Type: Grant
    Filed: March 23, 2001
    Date of Patent: September 19, 2006
    Assignee: Australian Nuclear Science & Technology Organisation
    Inventor: Suzanne V. Smith
  • Patent number: 6558556
    Abstract: A method of oxidizing an inorganic species in an aqueous solution of pH 5 or greater, comprises the steps of (i) supplying an oxidizable form of a sulfur compound, and oxygen to the solution; and (ii) adding a source of iron to the solution and allowing oxidation to take place. The method finds particular application in the treatment of manganese and other species in potable water, industrial waste waters and process liquors.
    Type: Grant
    Filed: March 27, 2001
    Date of Patent: May 6, 2003
    Assignees: Australian Nuclear Science and Technology Organisation, CRC for Waste Management & Pollution Control, Ltd.
    Inventors: Ging Hauw Khoe, Myint Zaw
  • Patent number: 6379649
    Abstract: The invention provides imidazo [1,2-a] pyridines of formula (1), wherein Y is selected from F, Cl, Br, I, OH, SH, NH2, CN and COOH; Z is selected from N(R3)C(O)R4 and C(O)NR3R4; R1, R2, R3, R4 can represent various radicals; m and n are independently 0, 1 or 2; and p is an integer from 1 to 4; radiolabelled derivatives and pharmaceutical compositions thereof. The compounds of the invention are useful for the diagnosis and treatment, including radiotherapy, of disorders that are characterized by an abnormal density of peripheral benzodiazepine receptors.
    Type: Grant
    Filed: January 3, 2001
    Date of Patent: April 30, 2002
    Assignee: Australian Nuclear Science & Technology Organisation
    Inventors: Andrew Katsifis, Filomena Mattner, Karin Mardon, Vahan Papazian, Branko Dikic
  • Patent number: 5807535
    Abstract: A physiologically acceptable, radiolabelled compound of general formula (I) consisting of a compound of the ##STR1## where k is an integer from 2 to 5l is an integer from 1 to 5X and Y are independently selected from phenyl, naphthyl, pyridine or quinoline radical, each having at position 2 one of --OH, --SH, --NH.sub.2 or --COOH and each of X and Y can be optionally substituted by one or more amino, halogen, hydroxy, mercapto, nitro, cyano, thiocyano, alkyl, alkoxy, halogenoalkyl, acyl, acylamino, acyloxy, carboxyl, alkoxycarbonyl, carbamoyl, pyridoylamino, N-carboxyalkyl-carbamoyl, sulpho, sulphamoyl, mono- or dialkylated or phenylated sulphamoyl which can also carry one or more substituents R', alkylsulphonyl, alkoxysulphonyl, or by an optionally hydroxy-containing phenylsulphonyl or phenoxysulphonyl; where R' is as defined for X and Y; or pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: December 15, 1995
    Date of Patent: September 15, 1998
    Assignee: Australian Nuclear Science & Technology Organisation
    Inventors: Suzanne V. Smith, Richard M. Lambrecht, Peter F. Schmidt, Fook-Thean Lee, Therese M. Donlevy, Nadine M. Di Bartolo
  • Patent number: 5496533
    Abstract: Rhenium complexes of formula (I), radiolabelled complexes thereof or pharmaceutically acceptable salts thereof: ##STR1## wherein R is straight or branched chain C.sub.1-10 alkyl, C.sub.1-10 alkenyl, C.sub.1-10 alkynyl optionally substituted by cycloalkyl or aryl; C.sub.1-10 cycloalkyl optionally substituted by straight or branched chain alkyl, alkenyl, alkynyl or aryl; or aryl optionally substituted by straight or branched chain alkyl, alkenyl, alkynyl or cycloalkyl for use in liver cancer therapy and metastasis of cancer.
    Type: Grant
    Filed: July 26, 1993
    Date of Patent: March 5, 1996
    Assignee: Australian Nuclear Science & Technology Organisation
    Inventors: Timothy W. Jackson, Masaharu Kojima, Richard M. Lambrecht